| Improving the human condition. |
 |
Discovery and Development | |
News & Recognition | |
 |
||||
|
 Profectus BioSciences, Inc. identifies and commercializes technologies intended to reduce the morbidity and mortality caused by viral diseases, especially Human Immunodeficiency Virus (HIV). Click here for more information on Profectus’s programs. |
 |
January 24, 2008: Profectus BioSciences Inc. Names Shawn Patrick O’Brien CEO. Learn More > July 19, 2007: Profectus BioSciences, Inc. Receives NIH Grant to Enhance Future Anti-HIV Therapies. Learn More > June 19, 2007: Profectus BioSciences, Inc. Announces NIH Grant. Learn More >
|
|
|
|
||||
